Central Nervous System Biomarker Detection Industry Research & Trends Analysis Report
Market IntelliX Research indicates the global market for Central Nervous System Biomarker Detection will achieve significant expansion, projecting growth from US$ 10230 million in 2025 to an estimated US$ 16740 million by 2031. This performance translates to a strong Compound Annual Growth Rate (CAGR) of 8.8% throughout the forecast period of 2025–2031.